Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 101–200 of 1,000
Wang, G., Zhang, Y., Zhang, R., Pan, J., Qi, D., Wang, J., & Yang, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.055 · Cited by 97
Probiotics and Postbiotics as the Functional Food Components Affecting the Immune Response
Szydłowska, A., & Sionek, B. (2022) · Microorganisms · doi:10.3390/microorganisms11010104 · Cited by 97
Sharma, G., & Im, S. (2018) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2018.10.6.575 · Cited by 97
Nutritional Health Perspective of Natto: A Critical Review
Afzaal, M., Saeed, F., Islam, F., Ateeq, H., Asghar, A., Shah, Y. A., Ofoedu, C. E., & Chacha, J. S. (2022) · Biochemistry Research International · doi:10.1155/2022/5863887 · Cited by 97
“*eir use with certain antibodies, especially for those who are severely ill, newborns, and the elderly, should be carefully monitored since reports of bacteremia in immune-prone patients treated with spores and other probiotics [62].”
BackgroundProbiotics and Postbiotics as an Alternative to Antibiotics: An Emphasis on Pigs
Ali, M. S., Lee, E., Hsu, W. H., Suk, K., Sayem, S. A. J., Ullah, H. M. A., Lee, S., & Park, S. (2023) · Pathogens · doi:10.3390/pathogens12070874 · Cited by 96
Liao, W., Chen, C., Wen, T., & Zhao, Q. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001464 · Cited by 97
Probiotics as a Possible Strategy for the Prevention and Treatment of Allergies. A Narrative Review
López-Santamarina, A., Gonzalez, E. G., Lamas, A., Mondragón, A. D. C., Regal, P., & Miranda, J. M. (2021) · Foods · doi:10.3390/foods10040701 · Cited by 96
The Role of Probiotics in Preventing Allergic Disease
Wang, H. T., Anvari, S., & Anagnostou, A. (2019) · Children · doi:10.3390/children6020024 · Cited by 95
Zhang, Y., Hou, B., Liu, T., Wu, Y., & Wang, Z. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115248 · Cited by 95
Relationship between Helicobacter pylori infection and gastrointestinal microecology
Xu, W., Xu, L., & Xu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.938608 · Cited by 94
“Additionally, excessive immune stimulation in susceptible individuals may be induced, as the use of Saccharomyces cerevisiae and Saccharomyces boulardii improved the risk of fungalemia in patients with prolonged antibiotics or venous catheterization deleterious metabolic activities (Doron and Snydman, 2015).”
BackgroundStrategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
The connection between microbiome and schizophrenia
Golofast, B., & Vales, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.011 · Cited by 92
Perillo, F., Amoroso, C., Strati, F., Giuffrè, M. R., Díaz‐Basabe, A., Lattanzi, G., & Facciotti, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155389 · Cited by 91
Antibiotic resistance propagation through probiotics
Daniali, M., Nikfar, S., & Abdollahi, M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1825682 · Cited by 90
Shu, Z., Li, P., Yu, B., Huang, S., & Chen, Y. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104559 · Cited by 88
Mantzourani, I., Chondrou, P., Bontsidis, C., Karolidou, K., Terpou, A., Alexopoulos, A., Bezirtzoglou, E., Galanis, A., & Plessas, S. (2019) · Annals of Microbiology · doi:10.1007/s13213-019-01467-6 · Cited by 88
“However, certain populations are potentially at risk, including cancer patients that undergo chemotherapy or radiation, pregnant women, and patients with structural heart disease (Doron and Snydman 2015).”
Probiotics for Neurodegenerative Diseases: A Systemic Review
Ojha, S., Patil, N., Jain, M., Kole, C., & Kaushik, P. (2023) · Microorganisms · doi:10.3390/microorganisms11041083 · Cited by 88
“Low levels of BDNF have been linked to several neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease [10].”
BackgroundA Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms
Ng, Q. X., Soh, A. Y. S., Venkatanarayanan, N., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2019) · Neuropsychobiology · doi:10.1159/000498862 · Cited by 87
Fermented dairy foods intake and risk of cardiovascular diseases: A meta-analysis of cohort studies
Zhang, K., Chen, X., Zhang, L., & Deng, Z. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1564019 · Cited by 87
“Recently, there has been increasing interest in their use to prevent, mitigate or treat specific diseases (Doron and Snydman 2015).”
BackgroundXu, M., Wang, J., Wang, N., Sun, F., Wang, L., & Liu, X.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141445 · Cited by 85
“This is important because live microorganisms can be linked to side effects such as sepsis and even death in vulnerable infants [28].”
BackgroundChen, Q., Ren, Y., Lu, J., Bartlett, M., Chen, L., Zhang, Y., Guo, X., & Liu, C. (2017) · Nutrients · doi:10.3390/nu9121341 · Cited by 84
“The key safety aspects for use of probiotic strains include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals and gene transfer [79].”
BackgroundDore, M. P., Bibbò, S., Fresi, G., Bassotti, G., & Pes, G. M. (2019) · Nutrients · doi:10.3390/nu11122913 · Cited by 83
Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
Tiderencel, K. A., Hutcheon, D. A., & Ziegler, J. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3213 · Cited by 82
“SUPPLEMENTATION IN T2DM Feizollahzadeh et al10 tested the effects of L plantarum supplementation on FPG in Iranian adults with T2DM.10 Subjects in the probiotic group (n = 20, mean duration of diabetes 6.9 ± 4.9 years) consumed soy milk enriched with 20 million CFU L plantarum A7 daily for 8 weeks.10 Subjects in the c…”
BackgroundInfluentialPakdaman, M. N., Udani, J. K., Molina, J. P., & Shahani, M. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0172-y · Cited by 82
“Alternatively, it has been suggested that initial use of Lactobacillus supplements may include abdominal discomfort and increased flatulence while the probiotic bacteria colonizes in the intestinal tract [53].”
BackgroundInflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
Mishra, J., Stubbs, M., Kuang, L., Vara, N., Kumar, P., & Kumar, N. (2022) · Mediators of Inflammation · doi:10.1155/2022/9621668 · Cited by 81
“These include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer, and gastrointestinal side effects [105].”
BackgroundOoi, S. L., Correa, D., & Pak, S. C. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.01.010 · Cited by 81
Role of Exposure to Lactic Acid Bacteria from Foods of Animal Origin in Human Health
Miranda, C., Contente, D., Igrejas, G., Câmara, S. P. D. A. E., Dapkevicius, M. D. L. E., & Poeta, P. A. C. Q. D. (2021) · Foods · doi:10.3390/foods10092092 · Cited by 79
Emerging Frontiers in Microbiome Engineering
Inda, M. E., Broset, E., Lu, T. K., & de la Fuente‐Núñez, C. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.08.007 · Cited by 78
“As systemic infections have been reported following probiotic treatment [89,90], it is important to characterize immune system–microbiome interactions to select the safest microbial strain for probiotic treatment or probiotic engineering, in addition to achieving the beneficial effect for the patient.”
BackgroundRizzo, M., Colletti, A., Penson, P. E., Katsiki, N., Mikhailidis, D. P., Toth, P. P., Gouni‐Berthold, I., Mancini, J., MARAIS, D. P., Moriarty, P. M., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106679 · Cited by 78
Hu, L., Zhou, M., Young, A., Zhao, W., & Yan, Z. (2019) · BMC Oral Health · doi:10.1186/s12903-019-0841-2 · Cited by 78
Khoury, S. E., Rousseau, A., Lecoeur, A., Cheaib, B. A., Bouslama, S., Mercier, P.-L., Demey, V., Castex, M., Giovenazzo, P., & Derôme, N. (2018) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2018.00058 · Cited by 78
“Finally, some cases of commercial probiotic induced microbiotahost perturbations were documented (Doron and Snydman, 2015; Durchschein et al., 2016).”
BackgroundApplication of Spray Dried Encapsulated Probiotics in Functional Food Formulations
Sharma, R., Rashidinejad, A., & Jafari, S. M. (2022) · Food and Bioprocess Technology · doi:10.1007/s11947-022-02803-6 · Cited by 77
“…studies should be conducted to evaluate their side effects and post-market surveillance of the consumers, and ideally, the administration in the immune compromised animals to determine the infectivity of the probiotic organism in this type of host should be investigated (Doron & Snydman, 2015).”
BackgroundProbiotics for the Prevention of Antibiotic-Associated Diarrhea
Kopacz, K., & Phadtare, S. (2022) · Healthcare · doi:10.3390/healthcare10081450 · Cited by 76
“Data emerging from clinical cases and trials, and experimental models have demonstrated potential risks [70].”
BackgroundHarms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota
Bafeta, A., Koh, M., Riveros, C., & Ravaud, P. (2019) · Annals of Internal Medicine · doi:10.7326/l18-0562 · Cited by 76
Sheyholislami, H., & Connor, K. L. (2021) · Nutrients · doi:10.3390/nu13072382 · Cited by 75
“In non-pregnant populations, adverse effects related to probiotic use have been reported, and include gastrointestinal side effects [22], such as abdominal cramping, nausea, soft stools, flatulence, and taste disturbance.”
BackgroundProbiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Ailioaie, L. M., & Litscher, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094942 · Cited by 75
Vale, G. C., & Mayer, M. P. A. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105174 · Cited by 75
Immunomodulatory Effects of Probiotic-Derived Extracellular Vesicles: Opportunities and Challenges
Chen, X., Li, Q., Xie, J., & Nie, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c04223 · Cited by 74
Sharma, M., Chandel, D., & Shukla, G. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2019.1615514 · Cited by 73
“Though probiotics have been found to be beneficial in CRC potential side effects such as bloating, excessive immune stimulation, systemic infections, septicemia or transfer of antibiotic resistance in certain individuals limit their application and metabiotics are gaining importance as an alternative agent (10,11).”
BackgroundCalcagnile, M., Tredici, S. M., & Alifano, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40892 · Cited by 73
Klarin, B., Adolfsson, A., Torstensson, A., & Larsson, A. (2018) · Critical Care · doi:10.1186/s13054-018-2209-4 · Cited by 73
Liu, Y., Wu, C.-R., & Huang, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113268 · Cited by 72
“Possible side ef‐ fects or adverse events resulting from the use of probiotics include gastrointestinal symp‐ toms such as abdominal cramping or diarrhea, skin manifestations such as rash or acne, excessive immune stimulation, and systemic infections such as bacteremia, endocarditis, and sepsis [48,49].”
BackgroundHygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings
Caselli, E. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12755 · Cited by 71
“…the use of probiotics for hospital sanitation regards their theoretical infectious risk, we wanted to address this point, as a few anecdotic cases of adverse events had been reported in the past (Logan, 1988), and there is a lack of systematic studies on probiotics safety (Doron and Snydman, 2015).”
BackgroundThe roles of gut microbiota and its metabolites in diabetic nephropathy
Zhao, H., Yang, C.-E., Liu, T., Zhang, M., Niu, Y., Wang, M., & Yu, J. Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1207132 · Cited by 70
“Probiotics may also have potential risks for patients with immunodeficiency as opportunistic pathogens (Doron and Snydman, 2015).”
BackgroundRoles of gut microbiota and metabolites in overweight and obesity of children
Zhang, S., & Dang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.994930 · Cited by 70
“Lactobacillus, a key genus of Firmicutes, is usually considered a probiotic with a long history of application (55).”
BackgroundGrujović, M. Ž., Semedo‐Lemsaddek, T., & Marković, K. G. (2025) · Foods · doi:10.3390/foods14173088 · Cited by 70
“…with autoimmune disorders or structural heart disease, particularly those with valvular abnormalities or a history of infective endocarditis; (iv) patients with acute abdominal conditions, active intestinal diseases (e.g., colitis), neutropenia, or those at risk of intestinal perforation [82,85].”
Awuchi, C. G., & Okpala, C. O. R. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.18317 · Cited by 69
Bacillus genus industrial applications and innovation: First steps towards a circular bioeconomy
Herrmann, L. W., Letti, L. A. J., Penha, R. D. O., Thomaz‐Soccol, V., Rodrigues, C., & Soccol, C. R. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108300 · Cited by 69
Bekiaridou, Α., Karlafti, E., Oikonomou, I. M., Ioannidis, A., & Papavramidis, T. S. (2021) · Nutrients · doi:10.3390/nu13124265 · Cited by 69
Microbiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 66
Seven cases of Saccharomyces fungaemia related to use of probiotics
Roy, U., Jessani, L. G., Rudramurthy, S. M., Gopalakrishnan, R., Dutta, S., Chakravarty, C., Jillwin, J., & Chakrabarti, A. (2017) · Mycoses · doi:10.1111/myc.12604 · Cited by 66
Garcia-Brand, A. J., Quezada, V., González, C., Bolaños-Barbosa, A. D., Cruz, J. C., & Reyes, L. H. (2022) · Fermentation · doi:10.3390/fermentation8030117 · Cited by 66
Diabetes and the Gut Microbiome
Lau, W. L., Tran, T., Rhee, C. M., Kalantar-Zadeh, K., & Vaziri, N. D. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.005 · Cited by 65
Liu, Y., Yu, X., Yu, L., Tian, F., Zhao, J., Zhang, H., Qian, L., Wang, Q., Xue, Z., Zhai, Q., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.06.026 · Cited by 65
Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis
López-Moreno, A., & Aguilera, M. (2020) · Nutrients · doi:10.3390/nu12030757 · Cited by 65
Cui, Y., Wang, S., Ding, S., Shen, J., & Zhu, K. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121266 · Cited by 64
Synthetic Biology Approaches in the Development of Engineered Therapeutic Microbes
Kang, M., Choe, D., Kim, K., Cho, B., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228744 · Cited by 64
“The unexpected results further include systemic infections, deleterious metabolic activities, excessive immune stimulation and gene transfer [23].”
BackgroundUse of yeasts in aquaculture nutrition and immunostimulation: A review
Mahdy, M. A., Jamal, M. T., Al-Harb, M., Al‐Mur, B. A., & Haque, M. F. (2022) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2022.100507 · Cited by 64
Probiotics for cow’s milk protein allergy: a systematic review of randomized controlled trials
Qamer, S., Deshmukh, M., & Patole, S. (2019) · European Journal of Pediatrics · doi:10.1007/s00431-019-03397-6 · Cited by 63
Targeting the gut microbiota for the treatment of irritable bowel syndrome
Herndon, C. C., Wang, Y., & Lu, C. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12154 · Cited by 62
“tion, sepsis reported following Lactobacillus, Bifidobacterium, and Saccharomyces supplementation, and endocarditis following L rhamnosus supplementation.(52) Brain fog was also recently reported”
BackgroundMüller, L., Kuhn, T., Koch, M., & Fuhrmann, G. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01136 · Cited by 62
Fermentation trip: amazing microbes, amazing metabolisms
Feng, R., Chen, L., & Chen, K. (2018) · Annals of Microbiology · doi:10.1007/s13213-018-1384-5 · Cited by 60
“, immunosuppressed individuals, pregnant women, and individuals with severe underlying diseases) are of primary concern (Doron and Snydman 2015; Khalesi et al. 2018).”
BackgroundNath, A., Molnár, M. A., Csighy, A., Kőszegi, K., Galambos, I., Pásztor‐Huszár, K., Koris, A. K., & Vatai, G. N. (2018) · Medicina · doi:10.3390/medicina54060098 · Cited by 60
Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections
Cruz, C. S., Ricci, M. F., & Vieira, A. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724033 · Cited by 60
“The use of inactivated probiotics is also of great interest because live probiotic microorganisms may cause systemic infections, excessive immune stimulation, and antibiotic resistance gene transfer (Doron and Snydman, 2015).”
BackgroundAlkalbani, N. S., Osaili, T. M. I., Al‐Nabulsi, A. A., Obaid, R. S., Olaimat, A. N., Liu, S., & Ayyash, M. M. (2022) · Journal of Fungi · doi:10.3390/jof8050544 · Cited by 60
Lu, S., Xu, J., Zhao, Z., Guo, Y., Zhang, H., Jurutka, P. W., Huang, D., Cao, C., & Cheng, S. (2023) · Food & Function · doi:10.1039/d3fo02018e · Cited by 59
The chemistry of gut microbiome in health and diseases
Lau, A., Tan, L. T., Mutalib, N. A., Wong, S. H., Letchumanan, V., & Lee, L. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000175 · Cited by 59
“Besides that, there are also insufficient studies to identify people at risk of consuming probiotics([293]).”
BackgroundInfluentialWei, C., Luo, K., Wang, M., Li, Y., Pan, M., Xie, Y., Qin, G., Liu, Y., Li, L., Liu, Q., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854131 · Cited by 59
“However, safety of probiotics has received increasing attention in recent years due to the potential transfer and spread of antibiotic resistance genes (ARGs) among microorganisms (Wang et al., 2008; Doron and Snydman, 2015).”
BackgroundProbiotics for oral and vulvovaginal candidiasis: A review
Shenoy, A., & Gottlieb, A. (2019) · Dermatologic Therapy · doi:10.1111/dth.12970 · Cited by 59
Anokyewaa, M. A., Amoah, K., Li, Y., Lu, Y., Kuebutornye, F. K. A., Asiedu, B., & Iddrisu, S. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100784 · Cited by 59
López‐Gómez, L., Alcorta, A., & Abalo, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13101487 · Cited by 58
Probiotics and the Treatment of Parkinson's Disease: An Update
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01128-w · Cited by 57
Immunostimulatory Effect of Heat-Killed Probiotics on RAW264.7 Macrophages
Noh, H.-J., Park, J. M., Kwon, Y. J., Kim, K., Park, S. Y., Kim, I., Lim, J. H., Kim, B. K., & Kim, B. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2201.01015 · Cited by 57
Chen, Y., Qi, A., Teng, D., Li, S., Yan, Y., Hu, S., & Du, X. (2022) · Techniques in Coloproctology · doi:10.1007/s10151-022-02585-1 · Cited by 57
“1 3 immune stimulation in susceptible individuals, gene transfer, and gastrointestinal side effects [36, 37].”
BackgroundBeneficial insights into postbiotics against colorectal cancer
Song, D., Wang, X., Ma, Y., Liu, N., & Wang, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1111872 · Cited by 56
Yang, G., Yu, J., Su, J.-H., Jiao, L.-G., Liu, X., & Zhu, Y. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00323 · Cited by 56
“Administration of a probiotic mixture of Lactobacillus spp. can alleviate disease signs of S. Typhimurium infection in weaned pigs (Casey et al., 2007), but several clinical trials have reported risks associated with LGG administration (Trevisi et al., 2011; Doron and Snydman, 2015).”
BackgroundMultifaceted toxin profile, an approach toward a better understanding of probioticBacillus cereus
Cui, Y., Märtlbauer, E. P., Dietrich, R., Luo, H., Ding, S., & Zhu, K. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1609410 · Cited by 56
“Therefore, it is very likely that some of these probiotics pose a potential threat to public health and may cause or aggravate symptoms in humans, particularly if applied to infants or immunocompromised patients (Doron and Snydman 2015).”
BackgroundAn introduction of the role of probiotics in human infections and autoimmune diseases
Sales-Campos, H., Soares, S. D. C., & Oliveira, C. J. (2019) · Critical reviews in microbiology · doi:10.1080/1040841x.2019.1621261 · Cited by 45
“…of reports describing undesirable side-effects or infections involving the consumption of Lactobacillus spp and Bifidobacterium spp is low, especially when compared to other genera e.g. Enterococcus and Streptococcus, that present a higher frequency of pathogenic species (Doron and Snydman 2015).”
BackgroundProbiotics and their increasing importance in human health and infection control
Ghasemian, A., Eslami, M., Shafiei, M., Najafipour, S., & Rajabi, A. (2018) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000147 · Cited by 56
The critical role of tumor microbiome in cancer immunotherapy
Yang, L., Wang, Q., He, L., & Sun, X. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2301801 · Cited by 55
“49 To surmount these challenges, researchers are concentrating on formulating more accurate and targeted approaches to modulate the tumor microbiome.”
BackgroundLactobacilli as Anti-biofilm Strategy in Oral Infectious Diseases: A Mini-Review
Giordani, B., Parolin, C., & Vitali, B. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.769172 · Cited by 55
Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia
Zeng, C., Yang, P., Cao, T., Gu, Y., Li, N., Zhang, B., Xu, P., Liu, Y., Luo, Z., & Cai, H. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110097 · Cited by 55
Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies
Bawany, F., Beck, L. A., & Järvinen, K. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.12.005 · Cited by 54
Mi, X.-J., Tran, T. H. M., Park, H.-R., Xu, X. Y., Subramaniyam, S., Choi, H. S., Kim, J., Koh, S. C., & Kim, Y. J. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110911 · Cited by 54
Streptococcus thermophilus Attenuates Inflammation in Septic Mice Mediated by Gut Microbiota
Han, F., Wu, G., Zhang, Y., Zheng, H., Han, S., Li, X., Cai, W., Liu, J., Zhang, W., Zhang, X., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.598010 · Cited by 53
“It has been reported that to the supplement of probiotics could treat or prevent a number of diseases by remediating gut microbial disorders, such as irritable bowel syndrome, hypercholesterolemia, gastritis, gut infection, parasitic infestation, hypersensitivity, and even cancers (Mombaerts et al., 1993; Doron and Sn…”
Prajapati, K., Bisani, K., Prajapati, H., Prajapati, S., Agrawal, D., Singh, S., Saraf, M. S., & Goswami, D. (2023) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-023-00208-w · Cited by 53
Mo, R., Zhang, X., & Yang, Y. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2018.09.007 · Cited by 52
Nutraceuticals as modulators of gut microbiota: Role in therapy
Quigley, E. M. M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14902 · Cited by 52
“In general, the safety record of probiotics is good (Didari, Solki, Mozaffari, Nikfar, & Abdollahi, 2014; Doron & Snydman, 2015) though, as pointed out in one review, the rigor of the literature on the safety of probiotics leaves much to be desired (Sanders et al., 2010)”
BackgroundLiu, Z., Yang, H., Li, S., Cai, G.-H., Ye, J., Zhang, C., & Sun, Y. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109370 · Cited by 52
Probiotics and their applications in functional foods: a health perspective
Amin, M. R., Biswas, A. P., Tasnim, M., Islam, M. N., & Azam, M. S. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101193 · Cited by 51
The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis
Bozkurt, H. S., & Quigley, E. M. M. (2020) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738420961304 · Cited by 51
Use of probiotics in pediatric infectious diseases
Caffarelli, C., Cardinale, F., Dascola, C. P., Dodi, I., Mastrorilli, V., & Ricci, G. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1096775 · Cited by 52
“Some case reports suggest that immunosuppressed or hospitalized children including preterm infants and children with food allergy, structural heart diseases, acute abdomen, active bowel dysfunction or intestinal disease should be considered potentially at risk for occurrence of adverse events after probiotic intake.[7…”
BackgroundGeraldo, B. M. C., Batalha, M. N., Milhan, N. V. M., Rossoni, R. D., Scorzoni, L., & Anbinder, A. L. (2020) · Journal of Periodontal Research · doi:10.1111/jre.12704 · Cited by 51
Meng, D., Hao, Q., Zhang, Q., Yu, Z., Liu, S., Yang, Y., Ran, C., Zhang, Z., & Zhou, Z. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739378 · Cited by 51
Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Antibiotics · doi:10.3390/antibiotics13080720 · Cited by 50
“Additionally, the antimicrobial substances produced by probiotics and postbiotics offer novel methods for handling antimicrobial resistance (AMR) [160].”
BackgroundPanpetch, W., Sawaswong, V., Chanchaem, P., Ondee, T., Dang, C. P., Payungporn, S., Tumwasorn, S., & Leelahavanichkul, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.561652 · Cited by 50
“However, several limitations on the similarity to patient obesity should be mentioned: (1) ingestion of 60% saturated fat diet is higher than most of the regular diets in human (80), (2) oral gavage also induced stress that might different from obesity in patients (81, 82), and (3) the dose of probiotics that is equiv…”
BackgroundLacy, B. E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14948 · Cited by 50
“For any IBS‐D therapy, both efficacy and safety profiles are critical aspects of the decision‐making process for ongoing symptom and disease management (Figure 1).(10,17,22,23,25,26,32,33,40,41,44,46,47,49,58,60,61,69,74,75,78,81,88,100) A survey study of 182 patients with IBS found that patients were will-”
BackgroundMethodInfluentialSaccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient
Kara, İ., Yıldırım, F., ., O. O., Erganiş, S., Aydoğdu, M., Dizbay, M., Gürsel, G., & Kalkancı, A. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.09.003 · Cited by 48
Sivamaruthi, B. S. (2018) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.228000 · Cited by 48
“Though the probiotics are used for preventing, managing and treating several diseases which are common, some of the unwanted side effects like GI side effects, unwarranted immune stimulation, systemic infections, gene transfer, and lethal metabolic activities have been seen in some group of people, who have undergone…”
BackgroundLi, Z., Li, M., Fang, X., Yu, D., & Hu, X. (2024) · Food & Function · doi:10.1039/d4fo04194a · Cited by 48
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.